Definitive Contract 75N91024C00093
Award Date
9/16/24
Potential Completion Date
9/15/26
Potential Value
$2M
Federal Agency
National Cancer Institute
Awardee
Omicscraft LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20001, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $455,000.00 Firm Fixed Price Definitive Contract to Omicscraft LLC, a minority-owned, small disadvantaged business, for a cloud-based liquid-biopsy platform to support the Cancer Research Data Commons. This contract falls under the ISYSMET program, which focuses on the development of cloud-based pipelines for integrative analysis of multi-omics and imaging data. The...
This contract was awarded by the National Cancer Institute, part of the Department of Health and Human Services National Institutes of Health, to Omicscraft LLC, a minority-owned, self-certified small disadvantaged business. The contract, valued at $272,135.01, is a Firm Fixed Price Definitive Contract for a Phase I SBIR (Small Business Innovation Research) project under Topic #364 titled "SYSMET: INTEGRATIVE SYSTEMS METABOLOMICS". The contract has a completion date of June 10, 2018...
<p>The National Cancer Institute (NCI) awarded a $300,000.00 Firm Fixed Price Definitive Contract to Newomics Inc. for the development of "OMICS-CHIPS FOR CTC ISOLATION AND MOLECULAR ANALYSIS". The contract has an ultimate completion date of September 12, 2014 and was awarded on September 13, 2013. This contract is not associated with any set-aside program. Newomics Inc. is a for-profit organization based in Moraga, California.</p>
The National Cancer Institute (NCI) awarded a Firm Fixed Price Definitive Contract to Navipoint Genomics LLC, a minority-owned small business, under the SBIR Program Phase II. The contract, valued at $1,679,321.00, is for the development of cloud-based software to support the Cancer Research Data Commons project. This project aims to enable precision oncology by facilitating collaboration in the cloud. The contract has a completion date of May 31, 2025 and is set aside for small businesses.
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Infotech Soft, Inc., a woman-owned small business. The contract, valued at $223,808.00, is for the development of a "Platform for High-Throughput Analysis of Integrated Cancer Imaging and Multi-Omics Data" under SBIR Topic #364. The contract is a Definitive Contract with a Firm Fixed Price...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI) to Infotech Soft Inc., a woman-owned small business. The $224,683 firm fixed-price contract is for the "SBIR TOPIC 341 PH I METABOLOMICS DATA INTEGRATION AND QUALITY ASSESSMENT" project, which aims to develop advanced technological solutions for medical research and diagnostic capabilities. The contract has a total small business set-aside designation and was awarded on...
The National Cancer Institute (NCI) awarded a $455,000.00 Firm Fixed Price Definitive Contract to Sostos Inc., a minority-owned, woman-owned small disadvantaged business. This Phase I contract is a Small Business Set Aside to develop a network-based multimodal data analysis cloud software for cancer biomarker discovery and drug development. The project, titled "TOPIC 464 PHASE I AWARD: NETWORK-BASED MULTIMODAL DATA ANALYSIS CLOUD SOFTWARE FOR CANCER BIOMARKER DISCOVERY AND DRUG...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Mediomics LLC, a woman-owned small business. The contract, valued at $185,116, is a firm-fixed-price definitive contract for research and development work. The contract was awarded on September 24, 2010 and has an ultimate completion date of June 23, 2011. As an SBIR Phase I contract, it is focused on the early-stage feasibility study of a...
<p>The National Cancer Institute (NCI) awarded a $199,996.00 Firm Fixed Price contract to Operational Technologies Corporation, a minority-owned, small disadvantaged, veteran-owned business, for Research & Development in Biomedical Basic Research. The contract has a completion date of June 22, 2014 and was set aside for small businesses. As a civilian agency, the NCI focuses on cancer research and this contract contributes to their broader medical research initiatives.</p>
<p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>